Are we "Livin" or just "Survivin"?
ByStephen Jones
Posted Date: Wednesday, December 26, 2007 | Viewed: 151
The inhibitor of apoptosis (IAP) family protects cells from self-execution by blocking the relentless caspase death cascade. IAPs bind to and inhibit activated caspases through their BIR domains. Some IAPs such as Livin also contain a RING domain that has E3 ubiquitin ligase activity and promotes the degradation of Smac/DIABLO through ubiquitination. Since Smac/DIABLO promotes apoptosis by inhibiting IAP-caspase interactions, degradation of Smac/DIABLO allows IAPs to more effectively block caspase activity thereby promoting cell survival.
In general, members of the IAP family are highly expressed in several types of cancer. However, Survivin, an IAP that lacks a RING domain, definitely stands out among the family for its clear association with cancer. Abundantly expressed during development but scarce in normal adult tissues, Survivin is upregulated during tumorigenesis and associated with chemotherapy resistance and poor patient survival.
IAPs are fast emerging as targets for potential diagnostics and therapeutics. For example, patients suffering from diverse cancers develop antibodies against Livin suggesting that Livin may be a novel diagnostic or prognostic tumor marker. Additionally, preclinical studies indicate that down-regulation of Survivin can sensitize tumor cells to chemotherapy, thereby increasing apoptosis and overall treatment response.
IMGENEX India Pvt Ltd. the only biotech company in Orissa and one of its kinds in Eastern India. IMGENEX India started in Oct as an outsourcing branch of IMGENEX Corporation, San Diego, USA. Find out more information about Apoptosis.
Related Articles on Cancer
- Adjuvant Therapy (keep cancer from returning)
by Lance Williams
Five main types of adjuvant therapy exist. Which adjuvant therapy is best for you is based on your t... - Cancer and Diet
by Lance Williams
The consensus on diet and cancer is that obesity increases the risk of developing cancer. Particular... - Late effects of cancer treatment
by Lance Williams
Late effects are side effects of cancer treatment that become apparent after your treatment has ende... - Cancer: No appetite? How to get the nutrition you need
by Lance Williams
Sometimes a particular illness or its treatment can affect your appetite. Though you might not feel ... - Bone density test
by Lance Williams
Years ago, the only time osteoporosis — the disease that causes bones to become more fragile and lik... - Gastric Cancer
by Lance Williams
Your stomach is a J-shaped organ in the upper abdomen where digestion begins before food is passed t... - 10 Options in Treating Mesothelioma
by Ira
As with any cancer, treatment for Mesothelioma depends on the location of the cancer, the progressio... - Akt Family: Antibodies from Imgenex
by Stephen Jones
Akt family of serine/threonine-directed kinases regulates a diverse array of biological processes, i... - Apoptosis Programmed Cell Death
by Stephen Jones
Apoptosis is regulated by death domain (DD) an... - ATM (Ataxia Telangiectasia Mutated) Antibodies from Imgenex
by Stephen Jones
ATM, the gene product mutated in the cancer susceptibility syndrome ataxia–telangiectasia, is relate... - QuikChIP Chromatin Immunoprecipitation Kits
by Stephen Jones
The principle of the ChIP assay is simple yet the process can be technically challenging. It is with... - Epigenetic and Signal Transduction Reagents
by Stephen Jones
IMGENEX offers over 90 Chromatin, DNA Methylation & Repair, and DNA Fragmentation-related antibodies... - Faces of DARPP-32: Master Signaling Mediator in the Brain?
by Stephen Jones
As a major target for dopamine-activated adenylyl cyclase and protein kinase A in the striatum, DARP... - GPR83: A Novel Treg Expressed Cell Surface Marker
by Stephen Jones
GPR83 is a member of the Orphan-A G-Protein coupled receptor family, and has anunknown ligand. It ha... - New FOXP3Δ2 (Exon 2 Deleted) Specific Antibody
by Stephen Jones
FOXP3 is a master regulator of immune homeostasis expressed specifically in CD4+ CD25+ T regulatory ... - GPR83: A Novel Treg Expressed Cell Surface Marker
by Stephen Jones
GPR83 is a member of the Orphan-A G-Protein coupled receptor family, and has anunknown ligand. It ha... - Colorectal Cancer Screening
by David Done
Colorectal Cancer Screening Methods Comparison - There are five main screening methods for colorecta...
